The efficacy, safety and tolerance of ceftazidime for the treatment of bacterial infections in the elderly.

Abstract

An open multicentre trial to study the efficacy and safety of ceftazidime in elderly patients has been conducted in four geriatric units on 135 subjects suffering from urinary-tract or respiratory-tract infections. Sixty-two patients were cured (45.9%), and 60 improved (44.4%). Of the evaluable cases bacteriological eradication was achieved in 91.3%. No adverse events were recorded.

• Authors: A Vozza, A M Zerman, L Bertoni, G C Cattini, L Tosto, N Greco, F Romano, R Panebianco, M Benedetti
• Journal: The Journal of hospital infection (J Hosp Infect) Vol. 15 Suppl A Pg. 87-9 (Apr 1990) ISSN: 0195-6701 [Print] England
• PMID: 1971652 (Publication Type: Clinical Trial, Journal Article, Multicenter Study)

Chemical References

• Ceftazidime

Topics

• Age Factors
• Aged
• Aged, 80 and over
• Bacterial Infections (drug therapy, microbiology)
• Ceftazidime (administration & dosage, adverse effects, therapeutic use)
• Female
• Humans
• Italy
• Male
• Multicenter Studies as Topic
• Respiratory Tract Infections (drug therapy, microbiology)
• Urinary Tract Infections (drug therapy, microbiology)